Biohaven (BHVN) Acquisitions (2024)
Biohaven (BHVN) reported Acquisitions of $391000.0 for Q1 2024.
Biohaven (BHVN) Acquisitions (2024) Analysis & Trends
Biohaven (BHVN) has 1 years of Acquisitions data on file, last reported at $391000.0 in Q1 2024.
- For the quarter ending Q1 2024, Acquisitions changed N/A year-over-year to $391000.0; the trailing twelve-month figure through Dec 2024 stood at $391000.0 (changed N/A YoY), and the FY2024 full-year result was $391000.0, changed N/A from the prior year.
- Acquisitions steadied at $391000.0 in Q1 2024.
- In the past five years, Acquisitions ranged from a high of $391000.0 in Q1 2024 to a low of $391000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Biohaven | 2.16 Bn | 1.81 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 391,000.00 |